IMRT-SIB with Concurrent and Neo-Adjuvant Platinum-Based Chemotherapy for Locally Advanced Head and Neck Squamous Cell Cancer: Analysis of Clinical Outcomes in a Retrospective Series of a Single Institution

Al-Sarraf M. , LeBlanc M. , Giri P.G. , Fu K.K. , Cooper J. , Vuong T. , Forastiere A.A. , Adams G. , Sakr W.A. , Schuller D.E. , Ensley J.F. : Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol, 16: 1310–1317, 1998.

Pignon J.P. , Bourhis J. , Domenge C. , Designe L. : Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. Meta-analysis of chemotherapy on head and neck cancer. Lancet, 355: 949–955, 2000.

Adelstein D.J. , Li Y. , Adams G.L. , Wagner H. Jr. , Kish J.A. , Ensley J.F. , Schuller D.E. , Forastiere A.A. : An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol, 21: 92–98, 2003.

Bernier J. , Domenge C. , Ozsahin M. , Matuszewska K. , Lefebvre J.L. , Greiner R.H. , Giralt J. , Maingon P. , Rolland F. , Bolla M. , Cognetti F. , Bourhis J. , Kirkpatrick A. , van Glabbeke M. : Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med, 350: 1945–1952, 2004.

Budach W. , Hehr T. , Budach V. , Belka C. , Dietz K. : A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer, 6: 28, 2006.

Cooper J.S. , Pajak T.F. , Forastiere A.A. , Jacobs J. , Campbell B.H. , Saxman S.B. , Kish J.A. , Kim H.E. , Cmelak A.J. , Rotman M. , Machtay M. , Ensley J.F. , Chao K.S. , Schultz C.J. , Lee N. , Fu K.K. : Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med, 350: 1937–1944, 2004.

Pignon J.P. , le Maitre A. , Maillard E. , Bourhis J. : Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol, 92: 4–14, 2009.

Bourhis J. , Sire C. , Graff P. , Gregoire V. , Maingon P. , Calais G. , Gery B. , Martin L. , Alfonsi M. , Desprez P. , Pignon T. , Bardet E. , Rives M. , Geoffrois L. , Daly-Schveitzer N. , Sen S. , Tuchais C. , Dupuis O. , Guerif S. , Lapeyre M. , Favrel V. , Hamoir M. , Lusinchi A. , Temam S. , Pinna A. , Tao Y.G. , Blanchard P. , Auperin A. : Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99–02): an open-label phase 3 randomised trial. Lancet Oncol, 13: 145–153, 2012.

Calais G. , Alfonsi M. , Bardet E. , Sire C. , Germain T. , Bergerot P. , Rhein B. , Tortochaux J. , Oudinot P. , Bertrand P. : Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst, 91: 2081–2086, 1999.

Denis F. , Garaud P. , Bardet E. , Alfonsi M. , Sire C. , Germain T. , Bergerot P. , Rhein B. , Tortochaux J. , Oudinot P. , Calais G. : Late toxicity results of the GORTEC 94–01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCICTC scoring systems. Int J Radiat Oncol Biol Phys, 55: 93–98, 2003.

Bourhis J. , Overgaard J. , Audry H. , Ang K.K. , Saunders M. , Bernier J. , Horiot J.C. , Le Maitre A. , Pajak T.F. , Poulsen M.G. , O'Sullivan B. , Dobrowsky W. , Hliniak A. , Skladowski K. , Hay J.H. , Pinto L.H. , Fallai C. , Fu K.K. , Sylvester R. , Pignon J.P. : Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet, 368: 843–854, 2006.

Bourhis J. , Lapeyre M. , Tortochaux J. , Rives M. , Aghili M. , Bourdin S. , Lesaunier F. , Benassi T. , Lemanski C. , Geoffrois L. , Lusinchi A. , Verrelle P. , Bardet E. , Julieron M. , Wibault P. , Luboinski M. , Benhamou E. : Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol, 24: 2873–2878, 2006.

Espeli V. , Zucca E. , Ghielmini M. , Giannini O. , Salatino A. , Martucci F. , Richetti A. : Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer. Oral Oncol, 48: 266–271, 2012.

Cvek J. , Kubes J. , Skacelikova E. , Otahal B. , Kominek P. , Halamka M. , Feltl D. : Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70–75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study. Strahlenther Onkol, 188: 666–670, 2012.

Veldeman L. , Madani I. , Hulstaert F. , De Meerleer G. , Mareel M. , De Neve W. : Evidence behind use of intensity-modulated radiotherapy: A systematic review of comparative clinical studies. Lancet Oncol, 9: 367–375, 2008.

Chao K.S. , Deasy J.O. , Markman J. , Haynie J. , Perez C.A. , Purdy J.A. , Low D.A. : A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys, 49: 907–916, 2001.

Bhide S.A. , Kazi R. , Newbold K. , Harrington K.J. , Nutting C.M. : The role of intensity-modulated radiotherapy in head and neck cancer. Indian J Cancer, 47: 267–273, 2010.

Fang F.M. , Chien C.Y. , Tsai W.L. , Chen H.C. , Hsu H.C. , Lui C.C. , Huang T.L. , Huang H.Y. : Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensitymodulated radiotherapy — a longitudinal study. Int J Radiat Oncol Biol Phys, 72: 356–364, 2008.

Wu Q. , Manning M. , Schmidt-Ullrich R. , Mohan R. : The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys, 46: 195–205, 2000.

Xia P. , Fu K.K. , Wong G.W. , Akazawa C. , Verhey L.J. : Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 48: 329–337, 2000.

Cozzi L. , Fogliata A. , Bolsi A. , Nicolini G. , Bernier J. : Three-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: comparative analysis of dosimetric and technical parameters. Int J Radiat Oncol Biol Phys, 58: 617–624, 2004.

Ferreira B.C. , do Carmo Lopes M. , Mateus J. , Capela M. , Mavroidis P. : Radiobiological evaluation of forward and inverse IMRT using different fractionations for head and neck tumours. Radiat Oncol, 5: 57, 2010.

Chao K.S. , Majhail N. , Huang C.J. , Simpson J.R. , Perez C.A. , Haughey B. , Spector G. : Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol, 61: 275–280, 2001.

Vergeer M.R. , Doornaert P.A. , Rietveld D.H. , Leemans C.R. , Slotman B.J. , Langendijk J.A. : Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys, 74: 1–8, 2009.

Roe J.W. , Carding P.N. , Dwivedi R.C. , Kazi R.A. , Rhys-Evans P.H. , Harrington K.J. , Nutting C.M. : Swallowing outcomes following intensity-modulated radiation therapy (IMRT) for head & neck cancer — a systematic review. Oral Oncol, 46: 727–733, 2010.

Nutting C.M. , Morden J.P. , Harrington K.J. , Urbano T.G. , Bhide S.A. , Clark C. , Miles E.A. , Miah A.B. , Newbold K. , Tanay M. , Adab F. , Jefferies S.J. , Scrase C. , Yap B.K. , A'Hern R.P. , Sydenham M.A. , Emson M. , Hall E. : Parotid-sparing intensity-modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. Lancet Oncol, 12: 127–136, 2011.

Fiorentino A. , Caivano R. , Metallo V. , Chiumento C. , Cozzolino M. , Califano G. , Clemente S. , Pedicini P. , Fusco V. : Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer. Br J Radiol, 85: 1415–1419, 2012.

Fiorentino A. , Cozzolino M. , Caivano R. , Pedicini P. , Chiumento C. , Oliviero C. , Clemente S. , Fusco V. : Cone-beam computed tomography dose monitoring during intensitymodulated radiotherapy in head and neck cancer: Parotid glands. Clin Transl Oncol, 15: 412–415, 2013.

Ho K.F. , Fowler J.F. , Sykes A.J. , Yap B.K. , Lee L.W. , Slevin N.J. : IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult. Acta Oncol, 48: 431–439, 2009.

Studer G. , Huguenin P.U. , Davis J.B. , Kunz G. , Lutolf U.M. , Glanzmann C. : IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients. Radiat Oncol, 1: 7, 2006.

Alongi F. , Bignardi M. , Garassino I. , Pentimalli S. , Cavina R. , Mancosu P. , Reggiori G. , Poletti A. , Ferrari D. , Foa P. , Bigoni A. , Dragonetti A. , Salvatori P. , Spahiu O. , Fogliata A. , Cozzi L. , Santoro A. , Scorsetti M. : Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients. Strahlenther Onkol, 188: 49–55, 2012.

UICC: TNM classification of malignant tumours, 7th edn, 2009.

Wu Q. , Mohan R. , Morris M. , Lauve A. , Schmidt-Ullrich R. : Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: Dosimetric results. Int J Radiat Oncol Biol Phys, 56: 573–585, 2003.

Milano M.T. , Constine L.S. , Okunieff P. : Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol, 17: 131–140, 2007.

Cox J.D. , Stetz J. , Pajak T.F. : Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31: 1341–1346, 1995.

Common terminology criteria for adverse events (CTCAE), version 4.0. National Cancer Institute, v4.03: June 14, 2010.

Messmer M.B. , Thomsen A. , Kirste S. , Becker G. , Momm F. : Xerostomia after radiotherapy in the head & neck area: Long-term observations. Radiother Oncol, 98: 48–50, 2011.

Eisbruch A. , Kim H.M. , Terrell J.E. , Marsh L.H. , Dawson L.A. , Ship J.A. : Xerostomia and its predictors following parotidsparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys, 50: 695–704, 2001.

Eisbruch A. , Harris J. , Garden A.S. , Chao C.K. , Straube W. , Harari P.M. , Sanguineti G. , Jones C.U. , Bosch W.R. , Ang K.K. : Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00–22). Int J Radiat Oncol Biol Phys, 76: 1333–1338, 2010.

Montejo M.E. , Shrieve D.C. , Bentz B.G. , Hunt J.P. , Buchman L.O. , Agarwal N. , Hitchcock Y.J. : IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys, 81: e845–852, 2011.

Leclerc M. , Maingon P. , Hamoir M. , Dalban C. , Calais G. , Nuyts S. , Serre A. , Gregoire V. : A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach. Radiother Oncol, 106: 333–340, 2013.

Brömme J.O. , Schmücking M. , Arnold A. , Giger R. , Rauch D. , Leiser D. , Plasswilm L. , Geretschläger A. , Ghadjar P. , Aebersold D.M. : Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy: outcome in patients with locally advanced head and neck cancer. Strahlenther Onkol, 189: 618–624, 2013.

Fowler J.F. , Harari P.M. , Leborgne F. , Leborgne J.H. : Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. Radiother Oncol, 69: 161–168, 2003.